Vial Announces $67M Series B Led by General Catalyst
Read Vial's feature in the WSJ

SAB

Dr. Adam Friedman joins Vial's Dermatology CRO

Vial Announces the Addition of Dr. Adam Friedman of the George Washington University School of Medicine and Health Sciences to their Dermatology CRO Scientific Advisory Board

San Francisco, CA. November 29, 2022 — Vial, a tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Adam Friedman, MD, to their Scientific Advisory Board. Dr. Friedman will advise Vial on enhancing its Dermatology CRO product and services. “We are thrilled to welcome Dr. Friedman to our SAB. We are confident he will contribute relevant and informed counsel to …

Vial Announces the Addition of Dr. Adam Friedman of the George Washington University School of Medicine and Health Sciences to their Dermatology CRO Scientific Advisory Board Read More »

Vial welcomes Dr. Rajesh Pahwa to their Neurology CRO.

Vial Welcomes Dr. Rajesh Pahwa, Chief of the Parkinson’s and Movement Disorder Division at the University of Kansas Medical Center, to its Central Nervous System Scientific Advisory Board

San Francisco, CA. November 16, 2022 — Vial welcomes Rajesh Pahwa, MBBS, MD, as a new Central Nervous System (CNS) advisory board member to their Neurology CRO. Dr. Pahwa is Chief of the Parkinson’s and Movement Disorder Division and a professor of neurology at the University of Kansas Medical Center, which has been designated as one of 33 Centers …

Vial Welcomes Dr. Rajesh Pahwa, Chief of the Parkinson’s and Movement Disorder Division at the University of Kansas Medical Center, to its Central Nervous System Scientific Advisory Board Read More »

Dr. Nathan Pennell

Oncology Expert, Dr. Nathan Pennell of the Cleveland Clinic Taussig Cancer Institute, Joins Vial’s Oncology CRO Advisory Board

San Francisco, CA. November 1 2022 — Dr. Nathan Pennell of the Cleveland Clinic Taussig Cancer Institute has joined Vial’s Oncology CRO Advisory Board. Dr. Pennell will advise Vial on enhancing its Oncology CRO product and services. Nathan Pennell, MD, Ph.D., FASCO, is a Professor of Medicine and the Director of the Lung Cancer Medical Oncology Program at the …

Oncology Expert, Dr. Nathan Pennell of the Cleveland Clinic Taussig Cancer Institute, Joins Vial’s Oncology CRO Advisory Board Read More »